ATE457997T1 - Impfstoff gegen burkholderia-infektionen - Google Patents

Impfstoff gegen burkholderia-infektionen

Info

Publication number
ATE457997T1
ATE457997T1 AT06726753T AT06726753T ATE457997T1 AT E457997 T1 ATE457997 T1 AT E457997T1 AT 06726753 T AT06726753 T AT 06726753T AT 06726753 T AT06726753 T AT 06726753T AT E457997 T1 ATE457997 T1 AT E457997T1
Authority
AT
Austria
Prior art keywords
vaccine against
proteins
protective
against burkholderia
burkholderia infections
Prior art date
Application number
AT06726753T
Other languages
English (en)
Inventor
David Neil Harland
Helen Susan Atkins
Nicola Jane Walker
Michelle Nelson
Timothy Phillip Atkins
Richard William Titball
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of ATE457997T1 publication Critical patent/ATE457997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT06726753T 2005-04-15 2006-04-13 Impfstoff gegen burkholderia-infektionen ATE457997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0507632.8A GB0507632D0 (en) 2005-04-15 2005-04-15 Vaccine
PCT/GB2006/001354 WO2006109071A2 (en) 2005-04-15 2006-04-13 Vaccine against burkholderia infections

Publications (1)

Publication Number Publication Date
ATE457997T1 true ATE457997T1 (de) 2010-03-15

Family

ID=34630731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06726753T ATE457997T1 (de) 2005-04-15 2006-04-13 Impfstoff gegen burkholderia-infektionen

Country Status (6)

Country Link
US (1) US20100055123A1 (de)
EP (1) EP1874806B1 (de)
AT (1) ATE457997T1 (de)
DE (1) DE602006012300D1 (de)
GB (2) GB0507632D0 (de)
WO (1) WO2006109071A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0519871D0 (en) 2005-09-30 2005-11-09 Secr Defence Immunogenic agents
RU2376031C1 (ru) * 2008-07-07 2009-12-20 Федеральное государственное учреждение здравоохранения Волгоградский научно-исследовательский противочумный институт Роспотребнадзора Способ повышения протективности мелиоидозных антигенов цитокинами
US8420090B2 (en) 2008-07-25 2013-04-16 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Recombinant B. pseudomallei adhesin protein and methods and uses thereof
US8029805B2 (en) * 2008-07-25 2011-10-04 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Recombinant B. pseudomallei adhesin protein and methods and uses thereof
GB0900455D0 (en) 2009-01-13 2009-02-11 Secr Defence Vaccine
US9267947B2 (en) 2011-03-28 2016-02-23 The Board Of Regents Of The University Of Texas System Compositions and methods for preventing or treating Burkholderia infection
WO2020243815A1 (en) * 2019-06-05 2020-12-10 Institut National De La Recherche Scientifique Tetrasaccharides for the diagnosis, prevention, and treatment of melioidosis and glanders
CN112941088B (zh) * 2021-02-04 2023-06-16 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 与布氏杆菌毒力相关的基因及其在布氏杆菌毒力评价及制备弱毒布氏杆菌中的应用
CN116655802B (zh) * 2023-05-25 2023-12-12 中国人民解放军陆军军医大学 类鼻疽菌Hcp1蛋白的融合蛋白、单克隆抗体、杂交瘤细胞株及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US6429199B1 (en) * 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
GB0519871D0 (en) * 2005-09-30 2005-11-09 Secr Defence Immunogenic agents
GB0615635D0 (en) * 2006-08-07 2006-09-13 Secr Defence Immunogenic proteins and uses thereof

Also Published As

Publication number Publication date
GB0507632D0 (en) 2005-05-25
EP1874806A2 (de) 2008-01-09
GB0720123D0 (en) 2007-11-28
GB2439259A (en) 2007-12-19
US20100055123A1 (en) 2010-03-04
WO2006109071A3 (en) 2006-12-14
DE602006012300D1 (de) 2010-04-01
EP1874806B1 (de) 2010-02-17
WO2006109071A2 (en) 2006-10-19
WO2006109071A8 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
CY1123052T1 (el) Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa)
CY1117757T1 (el) Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους
EA201070794A1 (ru) Рекомбинантные антигены rsv
EA201270063A1 (ru) Рекомбинантные антигены pcb
EA201000735A1 (ru) Композиции многотипных пептидов hpv и способы лечения или предотвращения папилломавирусной инфекции у человека
ATE503769T1 (de) Antikörper gegen das humane cytomegalie-virus (hcmv)
WO2010036938A3 (en) Nanoemulsion therapeutic compositions and methods of using the same
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
EP2136633A4 (de) Krebstherapie mit onkolytischem vacciniavirus
EA201001212A8 (ru) Лечение микробных инфекций
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MX2014004814A (es) Compuestos y metodos para mejorar las respuestas inmunes innatas.
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
DE602008002693D1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
MX2011007692A (es) Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion.
ATE452900T1 (de) Impfstoff gegen das west-nile-virus
EP2574170A4 (de) Immunstimulations- und impfstoffzusammensetzungen
MA37749B1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
EA201290792A1 (ru) Пептиды для вакцины против аллергии на березу
ATE457997T1 (de) Impfstoff gegen burkholderia-infektionen
EA201171001A1 (ru) Пептиды трав для вакцины
PH12017501100A1 (en) Recombinant swinepox virus and vaccines
EA201490758A1 (ru) Вакцины против вируса человеческой папилломы и способы их применения
ATE420658T1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
JOP20240233A1 (ar) بروتينات cd24 الطافرة واستخداماتها للوقاية من السرطان وعلاجه

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties